|
|
|
|
| TRADING CENTER |
6.61+0.06 / +0.92%
Elan Corp PLC (NYSE:ELN)
6.54-0.07 / -1.09
After hours quote
Prev. Close:
6.55
Open:
6.50
High:
6.65
Low:
6.50
Volume:
3,357,202
Volume Avg.:
4,918,000
52wk Range:
4.61 - 9.13
Market Cap (mil):
3,859.59
P/E Ratio:
0.00
Dividend Yield:
N/A
| 3 Reasons to Buy Dendreon Today - MotleyFool.com | |
| Another Acquisition for J&J - Analyst Blog - Zacks.com | |
| Five Biotech Events To Watch in 2010 - at TheStreet.com | |
| Abbott, Amgen are on the prowl with small deals - DailyFinance | |
| Forget the Higher Doses - MotleyFool.com | |
| Is This Company Really Earning Money? - MotleyFool.com | |
| Stocks in the news: Best Buy, Wells Fargo, GE, Goldman Sachs - DailyFinance | |
| Safety Dogs Elan Alzheimer's Drug; Seattle Genetics Finds New Partner: BioBuzz - at TheStreet.com | |
| UPDATE: Elan Halts High-Dose Drug Trial After Nine Deaths - Dow Jones | |
| This Just In: Upgrades and Downgrades - MotleyFool.com | |
| Finally Released From an Extended Review - MotleyFool.com | |
| Elan Drug Technologies Announces First Japanese Approval of Product Using Its NanoCry... - Business Wire | |
| Gilead Gets the Experts on Its Side - MotleyFool.com | |
| Elan to Present at Deutsche Bank Securities Biotech Boston Confab Conference - Business Wire | |
| Foreign Stocks You Can Actually Buy: Ireland - MotleyFool.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.33 | -0.04 / -0.06% | 14.05 |
| PFE | Pfizer Inc | 18.61 | 0.31 / 1.69% | 15.64 |
| NVS | Novartis AG | 53.80 | -0.41 / -0.76% | 15.11 |
Short Interest Date:
Nov 30 2009
Short Interest Shares:
12,655,481
Short Interest Ratio:
2.8
Float:
n/a
Short Interest as a % of Float:
n/a
Average Daily Volume:
3,838,100
Outstanding Shares:
471,413,777
Elan Corporation, plc, an Irish public limited company, is a neuroscience-based biotechnology company. It was incorporated as a private limited company in Ireland in December 1969 and became a public limited company in January 1984. It is a neuroscience-based biotechnology company that is focused ... (more)
| 2008 Revenue: | $1.0 B | Headquarters: Dublin 2, |
| Employees: | 1,687 | CEO: G. Kelly Martin |
| Net Income: | $-71,000,000.0 | Industry: Pharmaceuticals |
| Market Cap: | $3.1 B | Website: www.elan.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| ELN | 6.61 | +0.06 / +0.92% | 6.55 | 6.65 | 6.50 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
